Loading
OT
Osiris Therapeutics, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by LAW GREGORY IVAN, was filed 08 Jun 2015.
Osiris Therapeutics, Inc.: what insiders have been doing
This page follows insider dealings at Osiris Therapeutics, Inc. as filed with SEC (Form 4). Nothing new has been filed by managers of Osiris Therapeutics, Inc. in twelve months, the latest record being from 17 April 2019.
Since 2006, the database holds 11 purchases and 16 sales by insiders of the company.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
132
Thresholds
n/a
Buy Volume
€24M
11 ops. · all time
Sell Volume
€3M
16 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2018FY ended December 2018 · cache
Income statement
Revenue127.3M
Gross profit93.3M73% margin
Net income32.9M25.8% margin
Last declaration on 17 April 2019
Declarations132 total
9,375 shares@ US$19.00100.0% of flowCommon StockSEC:0001104659-19-021850:0
10,204,404 shares@ US$19.0068.9% of flowCommon StockSEC:0001104659-19-021852:0
4,103,301 shares@ US$19.0027.7% of flowCommon StockSEC:0001104659-19-021852:1
500,000 shares@ US$19.003.4% of flowCommon StockSEC:0001104659-19-021852:2
2,750 shares@ US$19.000.0% of flowCommon StockSEC:0001104659-19-021852:3
4,000 shares@ US$19.00100.0% of flowCommon StockSEC:0001104659-19-021851:0
3,000,000 shares0COMMON STOCKSEC:0001104659-18-046954:0
1,103,301 shares0COMMON STOCKSEC:0001104659-18-044310:0
5,000 shares@ US$5.1219.9% of flowCommon StockSEC:0001179110-17-001243:0
5,000 shares@ US$5.4821.3% of flowCommon StockSEC:0001179110-17-001243:1
5,000 shares@ US$5.3020.6% of flowCommon StockSEC:0001179110-17-001243:2
5,000 shares@ US$5.0319.6% of flowCommon StockSEC:0001179110-17-001198:0
5,000 shares@ US$4.7518.7% of flowCommon StockSEC:0001179110-17-000978:0
4,000 shares@ US$5.08Common StockSEC:0001179110-15-015239:0
37,500 shares@ US$6.84Common StockSEC:0001179110-15-015240:0
5,000 shares@ US$0.40Common StockSEC:0001179110-15-011953:0
2,425 shares@ US$18.22Common StockSEC:0001179110-15-011953:1
100 shares@ US$18.83Common StockSEC:0001179110-15-009306:0
Canonical exit: 2 Sept 2015 (T+90)
11,389 shares@ US$7.74Common StockSEC:0001179110-15-008722:0
3,751 shares@ US$6.46Common StockSEC:0001179110-15-008722:1
4,860 shares@ US$7.13Common StockSEC:0001179110-15-008722:2
20,000 shares@ US$18.55Common StockSEC:0001179110-15-008722:3
500 shares@ US$6.46Common StockSEC:0001179110-14-009419:0
500 shares@ US$15.55Common STockSEC:0001179110-14-009419:1
1,000 shares@ US$7.13Common StockSEC:0001179110-14-009316:0
25 of 132 declarations
About Osiris Therapeutics, Inc.
Osiris Therapeutics, Inc. is a company focused on developing regenerative therapies. It specializes in treatments based on stem cells and biomaterials.
